Early stage, highly accurate and unique cancer diagnostics
We are proud to announce that we have been selected as one of the 120 most promising deep tech companies in the European Union to join the prestigious European Innovation
We are pleased to announce that we have received a grant from the Recovery and Resilience plan of 3 million EUR. It is intended for the development of diagnostic tests
Prostate cancer represents growing burden on healthcare systems – direct costs related to its treatment and diagnostics in Slovakia grew by more than 2.5 times from 20 mil EUR in
We have accepted an invitation from Slovak television TA3 to discuss prostate cancer, which is one of the most common oncological diseases among men in Slovakia. Dr. Boris Kollarik, key
